CRISPR Pioneers Launch Helios: 1,000+ Protein Biomarkers From a Drop of Blood, Backed by YC
omarabudayyeh · x · 2026-11-19
Helios, a Y Combinator-backed biotech startup founded by CRISPR pioneers from Feng Zhang's lab, launched a longevity product measuring 1,000+ protein biomarkers from a drop of blood. Users self-collect blood at home with a needle-free device, and a Helios AI agent explains results, flags risks, and offers personalized guidance. The team's prior startups raised $400M; investors include Y Combinator and Formation VC.
More from Companies & People
- Altman hails Greg Brockman: 'OpenAI would not exist without him' — sama · 2026-11-19
- Mustafa Suleyman sits down with Yuval Harari on AI abundance, consciousness and flourishing — mustafasuleyman · 2026-11-19
- Sam Altman Admits He Has Secret "Empathy" — But Only for Jensen Huang — Calvinball_24 · 2026-11-19
- From Berkeley Lab to Startup: Arena Evaluates AI Models on Real Work — MattPerault · 2026-11-19
- From Berkeley lab to industry evaluator: the Arena founder story — MattPerault · 2026-11-19
- OpenAI's GPT-Live-1 engineering lead shares lessons testing voice models in housing and healthcare — pbbakkum · 2026-11-19